as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹34.85
Change
-0.08 (-0.23%)
Open
₹35.84
Prev. Close
₹34.93
Day High
₹36.24
Day Low
₹34.32
Volume Analysis
Traded
57,655
Delivered
35,082
Delivery %
60.85%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Promoter holding is falling
- •Below-average fundamentals quality score (37/100)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹37.88 | ₹37.06 | ₹35.96 | ₹35.14 | ₹34.04 | ₹33.22 | ₹32.12 |
| Fibonacci | ₹37.06 | ₹36.33 | ₹35.87 | ₹35.14 | ₹34.41 | ₹33.95 | ₹33.22 |
| Camarilla | ₹35.38 | ₹35.2 | ₹35.03 | ₹35.14 | ₹34.67 | ₹34.5 | ₹34.32 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-2.84%
1 Week
-1.94%
1 Month
-9.9%
3 Months
+3.08%
6 Months
+18.26%
1 Year
-1.55%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Vineet Laboratories Ltd scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 37/100. The strongest factor is Risk & Volatility (72/100), while Corporate Governance (15/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling; below-average fundamentals quality score (37/100).
TopFund Score — Fundamentals Quality
37/100 — WeakData confidence: 58/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
ROC Hyderabad grants two-month extension to hold Vineet Laboratories' 10th AGM by 30 November 2026.
Board approved FY26 audited results on August 25, 2026; typo corrected in approval date.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 61.34% | 62.2% | 62.5% | 62.49% | 63.93% | 64.15% | 64.15% | 70.74% | 84.11% | 87.54% | 93.67% | 93.52% |
| Promoters | 38.66% | 37.55% | 37.5% | 37.5% | 36.07% | 35.85% | 35.85% | 29.26% | 15.89% | 12.46% | 5.98% | 5.98% |
| FII | 0.0% | 0.24% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.36% | 0.5% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Vineet Laboratories Ltd (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 444,405 | 35.2 | 5.32 | 16.0% |
| Divi S Laboratories Ltd | 255,487 | 85.8 | 15.25 | 16.5% |
| Torrent Pharmaceuticals L | 189,746 | 85.0 | 20.11 | 27.4% |
| Apollo Hospitals Enter. L | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 115,890 | 23.8 | 4.32 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
Which Mutual Funds Hold Vineet Laboratories Ltd?
Frequently Asked Questions about Vineet Laboratories Ltd
Vineet Laboratories Ltd (VINEETLAB) closed at ₹34.85 on NSE on 25 September 2026, down 0.08 (0.23%) from the previous close.
Vineet Laboratories Ltd trades on the NSE (National Stock Exchange of India) under the symbol VINEETLAB.
Vineet Laboratories Ltd has a TopFund Quality Score of 37/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Vineet Laboratories Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.